연구동향 분석

Progress and Challenges in the Development of COVID-19 Vaccines and Current Understanding of SARS-CoV-2- Specific Immune Responses

김균도 황인수 구근본 이수민 김성준 Chonsaeng Kim 2020년

논문상세정보
인용/피인용
' Progress and Challenges in the Development of COVID-19 Vaccines and Current Understanding of SARS-CoV-2- Specific Immune Responses' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • COVID-19
  • Coronavirus
  • SARS-CoV-2
  • immune response
  • vaccine
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
6,203 0

0.0%

' Progress and Challenges in the Development of COVID-19 Vaccines and Current Understanding of SARS-CoV-2- Specific Immune Responses' 의 참고문헌

  • What we know so far : COVID-19 current clinical knowledge and research
    Lake MA [2020]
  • WHO declares COVID-19 a pandemic
    Cucinotta D [2020]
  • Viruses and interferons
    Sen GC [2001]
  • Virus-induced double-membrane vesicles
    Blanchard E [2015]
  • Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex
    Snijder EJ [2006]
  • Type I interferons in viral control and immune regulation
    Teijaro JR [2016]
  • Type I IFN-dependent T cell activation is mediated by IFNdependent dendritic cell OX40 ligand expression and is independent of T cell IFNR expression
    Kurche JS [2012]
  • Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome
    Liu W [2006]
  • Timely development of vaccines against SARS-CoV-2
    Lu S [2020]
  • The host immune response in respiratory virus infection : balancing virus clearance and immunopathology
    Newton AH [2016]
  • The COVID-19 epidemic
    Velavan TP [2020]
  • Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
    Yan R [2020]
  • Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome
    Li T [2004]
  • Severe outcomes among patients with Coronavirus Disease 2019(COVID-19)-United States, February 12-March 16, 2020
    Team CC-R [2020]
  • Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection
    Cheng VC [2007]
  • Serological and molecular findings during SARSCoV-2 infection : the first case study in Finland, January to February 2020
    Haveri A [2020]
  • Sensing of RNA viruses : a review of innate immune receptors involved in recognizing RNA virus invasion
    Jensen S [2012]
  • Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine : a phase 1, open-label, single-arm, dose-escalation trial
    Modjarrad K [2019]
  • Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine
    Lin JT [2007]
  • SARS-CoV-2 sensitive to type I interferon pretreatment
  • SARS vaccine development
    Jiang S [2005]
  • Recombinant adenoviral vaccine encoding the spike 1 subunit of the Middle East Respiratory Syndrome Coronavirus elicits strong humoral and cellular immune responses in mice
    Ababneh M [2019]
  • Recent advances in the vaccine development against Middle East respiratory syndrome-coronavirus
    Yong CY [2019]
  • Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice
    Coleman CM [2014]
  • Prospects for a MERS-CoV spike vaccine
    Zhou Y [2018]
  • Profile of specific antibodies to the SARS-associated coronavirus
    Li G [2003]
  • Preliminary identification of potential vaccine targets for the COVID-19 Coronavirus(SARS-CoV-2)based on SARS-CoV immunological studies
    Ahmed SF [2020]
  • Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome
    Wong CK [2004]
  • Perspectives on therapeutic neutralizing antibodies against the novel Coronavirus SARS-CoV-2
    Zhou G [2020]
  • Persistence of antibodies against Middle East Respiratory Syndrome Coronavirus
    Payne DC [2016]
  • Pattern recognition receptors and the innate immune response to viral infection
    Thompson MR [2011]
  • Overcoming CD4 Th1 cell fate restrictions to sustain antiviral CD8 T cells and control persistent virus infection
    Snell LM [2016]
  • Molecular pathology of emerging coronavirus infections
  • Middle East respiratory syndrome coronavirus-encoded ORF8b strongly antagonizes IFN-β promoter activation: its implication for vaccine design
  • Middle East respiratory syndrome coronavirus : another zoonotic betacoronavirus causing SARS-like disease
    Chan JF [2015]
  • Middle East respiratory syndrome
    Zumla A [2015]
  • Middle East Respiratory Syndrome Coronavirus-Encoded ORF8b Inhibits RIG-I-Like Receptors by a Differential Mechanism
    이정윤 [2019]
  • Middle East Respiratory Syndrome Coronavirus-Encoded Accessory Proteins Impair MDA5-and TBK1-Mediated Activation of NF-κB
    이정윤 [2019]
  • Middle East Respiratory Syndrome Coronavirus(MERS-CoV) : infection, immunological response, and vaccine development
    Mubarak A [2019]
  • MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile
  • Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome : a six-year follow-up study
    Tang F [2011]
  • Into the eye of the cytokine storm
    Tisoncik JR [2012]
  • Interferon-induced mx proteins : dynamin-like GTPases with antiviral activity
    Haller O [2002]
  • Innate immune response to viral infection
    Koyama S [2008]
  • Immunopathogenesis of coronavirus infections : implications for SARS
    Perlman S [2005]
  • Immune responses in COVID-19 and potential vaccines : Lessons learned from SARS and MERS epidemic
  • Immune phenotyping based on neutrophil-to-lymphocyte ratio and IgG predicts disease severity and outcome for patients with COVID-19
    Zhang B [2020]
  • Human Ebola virus infection results in substantial immune activation
    McElroy AK [2015]
  • Genomic characterisation and epidemiology of 2019 novel coronavirus : implications for virus origins and receptor binding
    Lu R [2020]
  • Generation of Full-Length Infectious cDNA Clones of Middle East Respiratory Syndrome Coronavirus
    이정윤 [2019]
  • Expression of elevated levels of pro-inflammatory cytokines in SARS-CoVinfected ACE2+ cells in SARS patients : relation to the acute lung injury and pathogenesis of SARS
    He L [2006]
  • Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients
    Zheng HY [2020]
  • Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
    Li Q [2020]
  • Dysregulation of immune response in patients with COVID-19 in Wuhan, China
    Qin C [2020]
  • Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice
  • Dynamic changes of T lymphocyte subsets in the long-term follow-up of severe acute respiratory syndrome patients
    Xie J [2006]
  • Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
    Wrapp D [2020]
  • Cross-reactivity of antibody against SARS-coronavirus nucleocapsid protein with IL-11
    Cheng M [2005]
  • Coronaviruses-drug discovery and therapeutic options
    Zumla A [2016]
  • Coronavirus infections and immune responses
    Li G [2020]
  • Clinical progression of patients with COVID-19 in Shanghai, China
    Chen J [2020]
  • Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
    Huang C [2020]
  • Clinical characteristics of coronavirus disease 2019 in China
    Guan WJ [2020]
  • COVID-19, an emerging coronavirus infection : advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics
    Dhama K [2020]
  • Breadth of concomitant immune responses prior to patient recovery : a case report of non-severe COVID-19
  • Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection
    Liu L [2019]
  • Age-dependent dysregulation of innate immunity
    Shaw AC [2013]
  • A pneumonia outbreak associated with a new coronavirus of probable bat origin
    Zhou P [2020]
  • A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial
    Martin JE [2008]